止血与血栓及基因治疗课题组
1. Shi X, Yang J, Cui X, Huang J, Long Z, Zhou Y, Liu P, Tao L, Ruan Z, Xiao B, Zhang W, Li D, Dai K, Mao J, Xi X: Functional effect of the mutations similar to the cleavage during platelet activation at integrin β3 cytoplasmic tail when expressed in mouse platelets. PLoS One 2016; 11(11):e0166136
2. Huang J, Zhou Y, Su X, Lyu Y, Tao L, Shi X, Liu P, Long Z, Ruan Z, Xiao B, Xi W, Zhou Q, Mao J, Xi X: Roles of integrin β3 cytoplasmic tail in bidirectional signal transduction in a trans-dominant inhibition model. Front Med 2016; 10(3):311-19
3. Shi X, Yang J, Huang J, Long Z, Ruan Z, Xiao B, Xi X: Effects of different shear rates on the attachment and detachment of platelet thrombi. Mol Med Rep 2016; 13(3):2447-56
4. Huang J, Shi X, Xi W, Liu P, Long Z, Xi X: Evaluation of targeting c-Src by the RGT-containing peptide as a novel antithrombotic strategy. J Hematol Oncol 2015; 8:62
5. Yan J, Wang K, Dong L, Liu H, Chen W, Xi W, Ding Q, Kieffer N, Caen JP, Chen S, Chen Z, Xi X: PML/RARα fusion protein transactivates the tissue factor promoter through a GAGC-containing element without direct DNA association. Proc Natl Acad Sci U S A 2010; 107:3716
6. Mao JH, Sun XJ, Liu JX, Zhang QY, Liu P, Huang QH, Li KQ, Chen Q, Chen Z, Chen SJ: As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia. Proc Natl Acad Sci USA 2010; 107:21683
7. Su X, Mi J, Yan J, Flevaris P, Lu Y, Liu H, Ruan Z, Wang X, Kieffer N, Chen S, Du X, Xi X: RGT, a synthetic peptide corresponding to the integrin β3 cytoplasmic C-terminal sequence, selectively inhibits outside-in signaling in human platelets by disrupting the interaction of integrin αIIbβ3 with Src kinase. Blood 2008; 112:592